Remsima 350 mg, solution à diluer pour perfusion

7680702360027 CH-70236 Lösung

Associated product:

REMSIMA sol perf 350 mg 1 pce

No image available

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
infliximabum
350.0 MG Substance Wirkstoff (Principe actif)
acidum aceticum
- Substance HNIDK
natrii acetas trihydricus
- Substance HNIDK
natrium
- Substance HBESI
sorbitolum
393.8 MG Substance HBESI
polysorbatum 80
4.4 MG Substance HBESI
aqua ad iniectabile
- Substance HNIDK

Authorization holder

IQONE HEALTHCARE SWITZERLAND

1290 Versoix

Authorization information

Swissmedic authorization number
70236
Drug name
Remsima, solution à diluer pour perfusion
Galenic form
LSINF
ATC Code
L04AB02
Authorization status
Z
Dispensing category
A
First authorization
03/07/2026
Authorization expiration date
02/07/2031
IT Number
07.15.0.
Domain
Human medicine

Package details

Description (FR)
REMSIMA sol perf 350 mg 1 pce
Description (DE)
REMSIMA Inf Lös 350 mg 1 Stk
Market launch
01/10/2026
Narcotic (BTM)
No

Other package sizes (1)

REMSIMA sol perf 100 mg 1 pce
1 DUR
GTIN: 7680702360010
View
Buy us a coffee Explore the data